Moderna (MRNA) Cash from Financing Activities (2018 - 2026)
Moderna's Cash from Financing Activities was $14 million in Q2 2026, up 55.6% from $9 million a year earlier but down 17.6% from the prior quarter.
Moderna (MRNA) Cash from Financing Activities (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Moderna's Cash from Financing Activities was $611 million through Jun 30, 2026; for FY2025, it came in at $593 million, up 958.9% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $56 million in FY2024, -$1.38 billion in FY2023, -$3.45 billion in FY2022 and -$873 million in FY2021.
- Quarterly Cash from Financing Activities has moved between -$1.33 billion (Q2 2022) and $581 million (Q4 2025) over five years.
- Compared with a year earlier, Cash from Financing Activities was higher in two of the last four quarters, with growth averaging 58.9%.
- Per Business Quant data, MRNA's Cash from Financing Activities in the three quarters before Q2 2026 was $17 million (Q1 2026), $581 million (Q4 2025) and -$1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 14.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | 581.00 Mn |
| Sep 30, 2025 | -1.00 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | -109.00 Mn |
| Sep 30, 2023 | -58.00 Mn |
| Jun 30, 2023 | -668.00 Mn |
| Mar 31, 2023 | -542.00 Mn |
| Dec 31, 2022 | -438.00 Mn |
| Sep 30, 2022 | -1.04 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Mar 31, 2022 | -642.00 Mn |
| Dec 31, 2021 | -873.00 Mn |
| Sep 30, 2021 | -2.00 Mn |
Moderna Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();